These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 20727768)
1. Commentary: the past, present and future of imaging in multiple sclerosis. Kam A J Clin Neurosci; 2010 Nov; 17(11):1482. PubMed ID: 20727768 [No Abstract] [Full Text] [Related]
2. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis. Filippi M; Rocca MA Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834 [No Abstract] [Full Text] [Related]
4. Magnetic resonance imaging in multiple sclerosis. Napoli SQ; Bakshi R Rev Neurol Dis; 2005; 2(3):109-16. PubMed ID: 16400309 [TBL] [Abstract][Full Text] [Related]
5. What do we really see when we look at magnetic resonance images? Filippi M; Hartung HP Ann Neurol; 2007 Sep; 62(3):207-9. PubMed ID: 17894367 [No Abstract] [Full Text] [Related]
6. The increasing influence of medical image processing in clinical neuroimaging. Barillot C Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52(6):16-23. PubMed ID: 17543205 [TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Moraal B; Pohl C; Uitdehaag BM; Polman CH; Edan G; Freedman MS; Hartung HP; Kappos L; Miller DH; Montalban X; Lanius V; Sandbrink R; Barkhof F Arch Neurol; 2009 Nov; 66(11):1345-52. PubMed ID: 19901165 [TBL] [Abstract][Full Text] [Related]
8. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153 [TBL] [Abstract][Full Text] [Related]
14. The role of MRS and fMRI in multiple sclerosis. Tartaglia MC; Arnold DL Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835 [TBL] [Abstract][Full Text] [Related]
15. The use of MRI as an outcome measure in clinical trials. Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836 [TBL] [Abstract][Full Text] [Related]
16. Quantification of multiple sclerosis lesion load and brain tissue volumetry using multiparameter MRI: methodology and reproducibility. Ding Z; Preiningerova J; Cannistraci CJ; Vollmer TL; Gore JC; Anderson AW Magn Reson Imaging; 2005 Apr; 23(3):445-52. PubMed ID: 15862645 [TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis lesion quantification using fuzzy-connectedness principles. Udupa JK; Wei L; Samarasekera S; Miki Y; van Buchem MA; Grossman RI IEEE Trans Med Imaging; 1997 Oct; 16(5):598-609. PubMed ID: 9368115 [TBL] [Abstract][Full Text] [Related]
18. MR image analysis in multiple sclerosis. Nyul LG; Udupa JK Neuroimaging Clin N Am; 2000 Nov; 10(4):799-816 ,x. PubMed ID: 11359726 [TBL] [Abstract][Full Text] [Related]
19. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Filippi M; Rocca MA; Calabrese M; Sormani MP; Rinaldi F; Perini P; Comi G; Gallo P Neurology; 2010 Nov; 75(22):1988-94. PubMed ID: 21115953 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging in multiple sclerosis. Haller S; Pereira VM; Lalive PH; Chofflon M; Vargas MI; Lövblad KO Top Magn Reson Imaging; 2009 Dec; 20(6):313-23. PubMed ID: 21187724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]